Business Description
Oculis Holding AG
ISIN : CH1242303498
Compare
Compare
Traded in other countries / regions
OCS.USAOCS.IcelandCR5.Germany IPO Date
2023-06-02Description
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 84.81 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -101.8 | |||||
| 3-Year EPS without NRI Growth Rate | -54.8 | |||||
| 3-Year FCF Growth Rate | -71.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -12.59 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.38 | |||||
| 9-Day RSI | 55.67 | |||||
| 14-Day RSI | 56.75 | |||||
| 6-1 Month Momentum % | 1.85 | |||||
| 12-1 Month Momentum % | 27.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.02 | |||||
| Quick Ratio | 4.02 | |||||
| Cash Ratio | 3.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | -9.34 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -72.03 | |||||
| ROA % | -57.75 | |||||
| ROIC % | -297.95 | |||||
| ROC (Joel Greenblatt) % | -5258.93 | |||||
| ROCE % | -70.2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.74 | |||||
| Price-to-Tangible-Book | 6.59 | |||||
| EV-to-EBIT | -7.04 | |||||
| EV-to-Forward-EBIT | -4.27 | |||||
| EV-to-EBITDA | -7.08 | |||||
| EV-to-Forward-EBITDA | -4.27 | |||||
| EV-to-Forward-Revenue | 558.02 | |||||
| EV-to-FCF | -9.2 | |||||
| Price-to-Net-Current-Asset-Value | 6.75 | |||||
| Price-to-Net-Cash | 7.28 | |||||
| Earnings Yield (Greenblatt) % | -14.2 | |||||
| FCF Yield % | -8.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oculis Holding AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.719 | ||
| Beta | 0 | ||
| Volatility % | 39.75 | ||
| 14-Day RSI | 56.75 | ||
| 14-Day ATR (€) | 0.026333 | ||
| 20-Day SMA (€) | 11 | ||
| 12-1 Month Momentum % | 27.17 | ||
| 52-Week Range (€) | 8.65 - 12.6 | ||
| Shares Outstanding (Mil) | 41.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oculis Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oculis Holding AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oculis Holding AG Frequently Asked Questions
What is Oculis Holding AG(FRA:CR5)'s stock price today?
The current price of FRA:CR5 is €11.00. The 52 week high of FRA:CR5 is €12.60 and 52 week low is €8.65.
When is next earnings date of Oculis Holding AG(FRA:CR5)?
The next earnings date of Oculis Holding AG(FRA:CR5) is 2025-03-18 Est..
Does Oculis Holding AG(FRA:CR5) pay dividends? If so, how much?
Oculis Holding AG(FRA:CR5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers